I agree that this site is using cookies. You can find further informations here.
X
Kavakli, Kaan
321  results:
Search for persons X
?
1

Accuracy and clinical role of digital templating for total ..:

Vahabi, Arman ; Er, Erdem ; Biçer, Elcil Kaya...
Haemophilia.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

Morphological analysis of patellofemoral joint in haemophil..:

Vahabi, Arman ; Biçer, Elcil Kaya ; Kayıkçı, Kayahan...
Haemophilia.  30 (2024)  2 - p. 531-537 , 2024
Link: https://doi.org/10.1111/..
 
?
3

Emicizumab prophylaxis in infants with hemophilia A (HAVEN ..:

Pipe, Steven W. ; Collins, Peter ; Dhalluin, Christophe...
Blood.  143 (2024)  14 - p. 1355-1364 , 2024
Link: https://doi.org/10.1182/..
 
?
4

Fitusiran prophylaxis in people with hemophilia A or B who ..:

Kenet, Gili ; Nolan, Beatrice ; Zulfikar, Bulent...
Blood.  143 (2024)  22 - p. 2256-2269 , 2024
Link: https://doi.org/10.1182/..
 
?
5

Rifampicin-Induced Toxic Hepatitis in a Patient with Hemoph..:

Uğur, Mehmet Can ; Aydoğdu, Semih ; Kaya Biçer, Elçil..
Turkish Journal of Hematology.  , 2024
Link: https://doi.org/10.4274/..
 
?
6

Recombinant porcine factor VIII in patients with congenital..:

Pfrepper, Christian ; Radossi, Paolo ; Windyga, Jerzy...
Haemophilia.  30 (2024)  2 - p. 395-403 , 2024
Link: https://doi.org/10.1111/..
 
?
7

HTRS2023.P2.9 Fitusiran prophylaxis demonstrates sustained ..:

Pipe, Steven W. ; Srivastava, Alok ; Young, Guy...
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 100232 , 2023
Link: https://doi.org/10.1016/..
 
?
8

S303: A PHASE 3 STUDY (ATLAS-PPX) TO EVALUATE EFFICACY AND ..:

Kenet, Gili ; Nolan, Beatrice ; Zulfikar, Bulent...
HemaSphere.  7 (2023)  S3 - p. e643526e , 2023
Link: https://doi.org/10.1097/..
 
?
9

Plasma‐derived human factor X concentrate for the treatment..:

Escobar, Miguel A. ; Kavakli, Kaan
Haemophilia.  30 (2023)  1 - p. 59-67 , 2023
Link: https://doi.org/10.1111/..
 
?
10

Efficacy and safety of fitusiran prophylaxis in people with..:

Young, Guy ; Srivastava, Alok ; Kavakli, Kaan...
The Lancet.  401 (2023)  10386 - p. 1427-1437 , 2023
Link: https://doi.org/10.1016/..
 
?
11

S301: CONSUMPTION OF FACTOR CONCENTRATES AND BYPASSING AGEN..:

Kenet, Gili ; Nolan, Beatrice ; Zulfikar, Bulent...
HemaSphere.  7 (2023)  S3 - p. e4531731 , 2023
Link: https://doi.org/10.1097/..
 
?
12

Management of haemophilia A with inhibitors: A regional cro..:

Peyvandi, Flora ; Kavakli, Kaan ; El‐Beshlawy, Amal.
Haemophilia.  28 (2022)  6 - p. 950-961 , 2022
Link: https://doi.org/10.1111/..
 
?
13

Are all licensed haemostatic agents for haemophilia therapy..:

Berger, Karin ; Batorova, Angelika ; Bohn, Rhonda...
Haemophilia.  28 (2022)  6 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
14

Long-term efficacy and safety of subcutaneous concizumab pr..:

Shapiro, Amy D. ; Angchaisuksiri, Pantep ; Astermark, Jan...
Blood Advances.  6 (2022)  11 - p. 3422-3432 , 2022
Link: https://doi.org/10.1182/..
 
?
15

Turoctocog alfa pegol (N8‐GP) in severe hemophilia A: Long‐..:

Lentz, Steven R. ; Kavakli, Kaan ; Klamroth, Robert...
Research and Practice in Thrombosis and Haemostasis.  6 (2022)  2 - p. e12674 , 2022
Link: https://doi.org/10.1002/..
 
1-15